Sightline Capital LLC

Sightline Capital provides discretionary investment management to a single private pooled vehicle, Meridian Target Seven Fund, LP, and advises exclusively on private equity investments rather than publicly traded securities or retail accounts. Like many private fund managers, the firm relies on asset-based management arrangements and limits its offerings to accredited and qualified investors.

The fund pursues a buy-and-build consolidation strategy focused on two healthcare verticals — anatomical pathology laboratories and medical service organizations — targeting platform acquisitions and add-on investments to build regional leaders. The firm’s investment process emphasizes sector-specific operational and regulatory due diligence (for example, reimbursement dynamics, clinician recruitment and state corporate practice requirements) and continuous portfolio oversight with formal quarterly reviews.

Noteworthy features include the unusually narrow sector focus on pathology labs and MSOs and the firm’s affiliations: an affiliated general partner that is entitled to carried interest (subject to escrow and clawback safeguards) and a separate ownership link to an exempt commodity pool operator, which the brochure discloses as a potential time-allocation and opportunity-allocation conflict. The adviser has not yet completed the fund’s initial closing and reports no regulatory assets under management, and its small founding team combines prior public-markets and operational experience.